Mission Therapeutics promotes Paul Thompso...Today Mission Therapeutics, a drug discovery and development company focused on treating fibrosis, neurodegenerative and other diseases by selectively targeting deubiquitylating enzymes (DUBs), announced … more ➔
Rentschler Biopharma appoints Federico Pol...Rentschler Biopharma SE, a service provider for biopharmaceuticals, today announced the appointment of Mr. Federico Pollano as the new Senior Vice President of Business Development, effective March … more ➔
EU-Commission appoints Jean-Eric PaquetPaquet is a French national who since November 2015 has served as one of the three Deputy Secretaries-General of the Juncker Commission, and has now been been appointed as Director General of DG Research … more ➔
Mereo BioPharma Appoints Wills Hughes-Wils...Mereo BioPharma Group plc, a multi-asset biopharmaceutical company focused on the acquisition, development and commercialization of innovative therapeutics that aim to improve outcomes for patients with … more ➔
Sigurdur Olafsson appointed CEO of HikmaHikma Pharmaceuticals today announces its Board of Directors has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer. Mr Olafsson will also join Hikma’s Board of Directors as an executive … more ➔
Addex Appoints Jean-Philippe Rocher as Co-...Addex Therapeutics, a leading company in allosteric modulation-based drug discovery and development, announced today the appointment of Jean-Philippe Rocher, PhD, as Co-Head of Discovery and Member of … more ➔
Selvita appoints new Chief Medical OfficerSelvita S.A., a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, announced today the appointment of Steffen Heeger, … more ➔
Rentschler Biopharma SE appoints Dr. Ralf...Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February … more ➔
Storm Therapeutics Appoints Nobel Prize Wi...Storm Therapeutics today announced the appointment of Nobel Prize Winner Professor Thomas Cech as a Scientific Advisor. This appointment follows STORM Therapeutics’ successful Series A Financing Extension … more ➔
Congenica Appoints New CEOCongenica, a global provider of clinical genomics interpretation software, today announced the appointment of its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in … more ➔
